JSC “Grindeks” informs, that its subsidiary “Namu apsaimniekošanas projekti” owns a land in Riga, near by the Salu Bridge. The land is not meant for pharmaceutical products manufacturing needs and is planned for development of real estate projects.

The progress of the projects depends on decision of Riga Municipality Business Development and Investments Council as well as overall real estate market trends in Latvia.

About “Grindeks”
“Grindeks” is the leading pharmaceutical company in the Baltic States. The main directions of its operation are research, development, manufacturing and sales of original products, as well as generics and active pharmaceutical ingredients. “Grindeks” specializes in the heart and cardiovascular, psychotropic and anti-cancer therapeutic groups of medications.
„Grindeks” concern consists of four subsidiary companies in Latvia, Estonia and Russia; as well as representatives and representative offices in 14 countries. Products of the company are exported to more than 40 countries and its export comprises more than 96% of the total turnover. The main markets are the Baltic States, Russia and other CIS countries, as well as Japan and USA. The shares of JSC „Grindeks” are listed in the Official List of „NASDAQ OMX Riga”.

Further information:

Laila Kļaviņa
Head of the Communications Department
JSC “Grindeks”
E-mail: laila.klavina@ grindeks.lv
Phones: +371 67083370, +371 29256012